Inventor · disambiguated record
Stefan Laufer
Also filed as: LAUFER STEFAN
22 granted patents·12 pending applications·211 citations·filing 1995–2023
94Inventor score
Top patents by PatentIndex Score
34 records- 0179US11040027B2Protein kinase inhibitors for promoting liver regeneration or reducing or preventing hepatocyte deathHEPAREGENIX GMBH·Filed 2018·Granted Jun 22, 2021·5 cites·15 claims
- 0279US8633312B2Dibenzocycloheptatone derivatives and pharmaceutical agents containing said compoundsLAUFER STEFAN·Filed 2009·Granted Jan 21, 2014·7 cites·15 claims
- 0379US5942535Aa!-Annelated pyrrole derivatives and pharmaceutical use thereofMERCKLE GMBH·Filed 1995·Granted Aug 24, 1999·54 cites·9 claims
- 0478US5939415AA!-annellated pyrrole derivatives and their use in pharmacologyMERCKLE GMBH·Filed 1995·Granted Aug 17, 1999·52 cites·15 claims
- 0577US11912701B2Protein kinase inhibitors for promoting liver regeneration or reducing or preventing hepatocyte deathHEPAREGENIX GMBH·Filed 2019·Granted Feb 27, 2024·2 cites·18 claims
- 0677US5958943AA!-anellated pyrrole derivatives and their use in pharmacologyMERCKLE GMBH·Filed 1995·Granted Sep 28, 1999·50 cites·12 claims
- 0772US11858927B2Protein kinase MKK4 inhibitors for promoting liver regeneration or reducing or preventing hepatocyte deathHEPAREGENIX GMBH·Filed 2019·Granted Jan 2, 2024·1 cites·19 claims
- 0871US8519155B2Choline and tromethamine salt of licofeloneALBRECHT WOLFGANG·Filed 2009·Granted Aug 27, 2013·1 cites·3 claims
- 0971US6936632B2Fused pyrrole compounds, pharmaceutical agents containing the same, and the use thereofMERCKLE GMBH·Filed 2001·Granted Aug 30, 2005·9 cites·14 claims
- 1070US11731968B2Tricyclic protein kinase inhibitors for promoting liver regeneration or reducing or preventing hepatocyte deathHEPAREGENIX GMBH·Filed 2019·Granted Aug 22, 2023·1 cites·11 claims
- 1167US12264158B2Protein kinase MKK4 inhibitors for promoting liver regeneration or reducing or preventing hepatocyte deathHEPAREGENIX GMBH·Filed 2023·Granted Apr 1, 2025·0 cites·7 claims
- 1266US7253191B22-thio-substituted imidazole derivatives and the use thereof in the pharmaceutical industryMERCKLE GMBH·Filed 2002·Granted Aug 7, 2007·6 cites·12 claims
- 1365US6417371B1Process for preparing 6-(4-chlorophenyl)-2,2-dimethyl-7-phenyl-2,3-dihydro-1H-pyrrolizin-5-yl-acetic acidMERCKLE GMBH·Filed 2001·Granted Jul 9, 2002·4 cites·18 claims
- 1464US7442713B22-thio-substituted imidazole derivatives and their use in pharmaceuticsMERCKLE GMBH·Filed 2003·Granted Oct 28, 2008·3 cites·14 claims
- 1563US2023348462A1Imidazo[4,5-c]quinoline compounds and their use as atm kinase inhibitorsDEUTSCHES KREBSFORSCH·Filed 2023·Application pending·0 cites
- 1661US7582660B22-thio-substituted imidazole derivatives and their use in pharmaceuticsC A I R BIOSCIENCES GMBH·Filed 2003·Granted Sep 1, 2009·2 cites·23 claims
- 1761US7078535B2Method for the production of 6-(4-chlorophenyl)-2,2-dimethyl-7-phenyl-2,3-dihydro-1h-pyrrolizin-5-ylacetic acidMERCKLE GMBH·Filed 2002·Granted Jul 18, 2006·2 cites·48 claims
- 1860US6867211B24-Pyridyl-and 2,4-pyrimidinyl-substituted pyrrole derivatives and their use in pharmacyMERCKLE GMBH·Filed 2001·Granted Mar 15, 2005·2 cites·3 claims
- 1960US2023406838A1Mutant selective egfr inhibitors and methods of use thereofDANA FARBER CANCER INST INC·Filed 2023·Application pending·0 cites
- 2058US12466826B23-benzoyl-1H-pyrrolo[2,3-b]pyridine derivatives as MKK4 inhibitors for treating liver diseasesHEPAREGENIX GMBH·Filed 2021·Granted Nov 11, 2025·0 cites·13 claims
- 2156US2010099730A1Annellated pyrrole compounds for cancer managementMERCKLE GMBH·Filed 2007·Application pending·0 cites
- 2255US2024101538A1Protein-protein interaction modulators of aurora kinase a and their use in the prevention and/or treatment of cancerUNIV EBERHARD KARLS TUEBINGEN·Filed 2021·Application pending·0 cites
- 2351US2009098536A1Method for subgroup analysis in subjects having or being suspected of having inflammatory disease, use of anti-p38MAPK antibodies, kits and their useC A I R BIOSCIENCES GMBH·Filed 2007·Application pending·0 cites
- 2449US2022340561A1Heteroaryl-substituted pyrazolo-pyridine protein kinase inhibitors for promoting liver regeneration or reducing or preventing hepatocyte deathHEPAREGENIX GMBH·Filed 2020·Application pending·0 cites
- 2546US6432988B12-arylalkylthio -imidazoles, 2-arylalkenyl -thio -imidazoles and 2-arylalkinyl -thio -imidazoles as anti -inflammatory substances and substances inhibiting the release of cytokineMERCKLE GMBH·Filed 1999·Granted Aug 13, 2002·10 cites·14 claims
- 2644US2023017312A1Centrally active p38alpha inhibiting compoundsSYNOVO GMBH·Filed 2020·Application pending·0 cites
- 2744US2010069436A1Imidazole compounds having an antiinflammatory effectMerckle·Filed 2007·Application pending·0 cites
- 2843US2009221697A1Macrolide conjugates of pyrrolizine and indolizine compounds as inhibitors of 5-lipooxygenase and cyclooxygenaseMERCKLE GMBH·Filed 2006·Application pending·0 cites
- 2942US8143294B22-sulfanyl-substituted imidazole derivatives and their use as cytokine inhibitorsBURNET MICHAEL·Filed 2008·Granted Mar 27, 2012·0 cites·11 claims
- 3042US8034837B2Polymorphic form of 6-(4-chlorophenyl)-2,2-dimethyl-7-phenyl-2,3-dihydro-1h-pyrrolizin-5-ylacetic acidMERCKLE GMBH·Filed 2006·Granted Oct 11, 2011·0 cites·7 claims
- 3142US2009105327A1Dibenzocycloheptane compounds and pharmaceuticals containing these compoundsMERCKLE GMBH·Filed 2006·Application pending·0 cites
- 3241US2010273833A12-sulfinyl- and 2-sulfonyl-substituted imidazole derivatives and their use as cytokine inhibitorsALBRECHT WOLFGANG·Filed 2006·Application pending·0 cites
- 3340US2006128759A1Substituted isoxazole derivatives and their use in pharmaceuticsMERCKLE GMBH·Filed 2003·Application pending·0 cites
- 3428US6878738B1Anti-inflammatory oxo derivatives and hydroxy derivatives of pyrrolizines, and their pharmaceutical useMERCKLE GMBH·Filed 1999·Granted Apr 12, 2005·0 cites·11 claims
Join the waitlist — get patent alerts
Get an alert when Stefan Laufer files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →